Chariklia Neophytou

Dr. Chariklia Neophytou

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2024 in Applied Sciences
Verified
Journal Article
Open access
PDF file
PGParaskevi Giannakopoulou
Paraskevi Giannakopoulou
CNChariklia Neophytou
Chariklia Neophytou
PKPanagiotis Karakostas
Panagiotis Karakostas
Konstantinos PapadimitriouKonstantinos Papadimitriou
Konstantinos Papadimitriou
Dimitrios DionysopoulosDimitrios Dionysopoulos
Dimitrios Dionysopoulos
SDSotiria Davidopoulou
Sotiria Davidopoulou
Tooth bleaching is a popular cosmetic procedure known for its effective whitening results. However, it may cause tooth sensitivity. Various desensitizing therapies, including laser treatments, are used to alleviate pain and improve patient comfort. This study aims to conduct a systematic review to evaluate the effectiveness of low-level laser therapy for treating tooth sensitivity following bleaching therapy. A comprehensive search was conducted across 13 electronic databases (PubMed, Scopus, ScienceDirect, Google Scholar, Web of Science, Ovid, BMJ evidence-based medicine, proQuest, Greylit.org, Ethos, Livivo, Clinical trials gov, and Meta register of controlled trials) to identify relevant studies according to specific eligibility criteria, following the PRISMA guidelines. Two independent reviewers screened and selected the studies, performed data extraction, and assessed the risk of bias using the revised Cochrane risk-of-bias tool for randomized clinical trials (RCTs). The initial search yielded 2875 articles, which were subsequently screened to remove duplicates. After evaluating 1532 articles based on title and 136 by abstract, 21 studies remained for full-text assessment. Ultimately, only six RCTs met all of the eligibility criteria. The application of low-level laser therapy appears to reduce tooth sensitivity following tooth bleaching. Despite the positive reported effects, further research is necessary to determine the optimal use of low-level laser therapy for effective pain relief.

12 January 2026 in Dentistry Journal
Verified
Journal Article
Open access
PDF file
CNChariklia Neophytou
Chariklia Neophytou
EVElpiniki Vlachodimou
Elpiniki Vlachodimou
EKEleftherios G. Kaklamanos
Eleftherios G. Kaklamanos
DSDimitra Sakellari
Dimitra Sakellari
Konstantinos PapadimitriouKonstantinos Papadimitriou
Konstantinos Papadimitriou
Background: Peri-implantitis, a condition characterized by inflammation and progressive bone loss around dental implants, presents a significant challenge in contemporary dentistry. Conventional non-surgical treatments often fail to fully eliminate bacterial biofilms, particularly on complex implant surfaces. Laser therapies have emerged as potential adjuncts due to their antimicrobial and bio-modulatory properties. However, their microbiological effectiveness and suitability for individualized patient treatment planning remain unclear. Objective: Τhis study aims to systematically assess and synthesize the microbiological effects of various laser-assisted non-surgical treatments for peri-implantitis compared to conventional mechanical debridement. Methods: This systematic review and meta-analysis followed PRISMA guidelines and was registered in PROSPERO (CRD420251035354). Randomized controlled trials (RCTs) evaluating microbiological changes following laser-assisted non-surgical treatment of peri-implantitis, with a minimum follow-up of one month, were identified through searches in multiple databases and registries up to February 2025. The ncluded studies used lasers such as diode, Er: YAG, and photodynamic therapy (PDT) either alone or as adjuncts to mechanical debridement. Outcomes of interest included bacterial counts. Risk of bias was assessed using the RoB2 tool, and certainty of evidence was evaluated via GRADE. Quantitative synthesis used random-effects meta-analysis, with standardized mean differences (SMDs) calculated. Results: Eight RCTs involving 266 patients and 335 implants were included in the systematic review. Quantitative synthesis of three pathogens (counts of Fusobacterium nucleatum, P. gingivalis, T. denticola) across three studies displayed no statistically significant differences between laser and control groups at 3 and 6 months (p > 0.05 for all comparisons). When examining individual study findings, PDT, particularly in patients with diabetes or acute abscess, showed short-term reductions in red complex bacteria (e.g., Porphyromonas gingivalis and Treponema denticola). In contrast, diode and Er: YAG lasers demonstrated inconsistent or transient effects. The quality of evidence was rated as very low according to GRADE. Conclusions: Laser-assisted therapies, especially PDT, may provide targeted microbiological benefit in selected patient groups, supporting their adjunctive use within personalized treatment planning rather than as replacements for mechanical debridement, which remains the gold standard. Further high-quality RCTs incorporating well-defined patient risk profiles, such as systemic conditions and behavioral factors, and precision treatment algorithms are needed.

25 November 2025 in The Journal of Contemporary Dental Practice
Verified
Journal Article
Closed access
CNChariklia Neophytou
Chariklia Neophytou
ANAvra Maria Neofytou
Avra Maria Neofytou
SDSotiria Davidopoulou
Sotiria Davidopoulou
EKEleftherios G Kaklamanos
Eleftherios G Kaklamanos
DGDimitrios G Goulis
Dimitrios G Goulis
Konstantinos PapadimitriouKonstantinos Papadimitriou
Konstantinos Papadimitriou
To evaluate the role of erbium lasers (Er:YAG and Er,Cr:YSGG) as adjuncts in access flap periodontal surgery and their potential contribution to personalized, minimally invasive periodontal care. Periodontal surgery has progressively evolved toward minimally invasive techniques prioritizing tissue preservation, enhanced healing, and reduced morbidity. Erbium lasers represent a significant advancement by offering precise tissue ablation, improved decontamination, and favorable patient experiences compared to conventional approaches. Evidence shows that erbium lasers achieve clinical outcomes comparable to or better than traditional flap surgery. Benefits include reduced postoperative discomfort, minimized gingival recession (GR), and enhanced patient satisfaction. While gains in clinical attachment level are modest yet statistically significant in some studies, patient-reported outcomes (PROs) consistently favor erbium-assisted interventions. Erbium lasers enhance access flap surgery by supporting precision, soft tissue preservation, and improved patient-centered outcomes. Current data suggest they are valuable adjuncts, though long-term trials are still needed to establish standardized protocols. Integration of erbium lasers into periodontal flap surgery supports personalized and minimally invasive care, aligning with modern principles of precision periodontics and improving both clinical and PROs. How to cite this article: Neophytou C, Neofytou AM, Davidopoulou S, et al. Erbium Laser-assisted Access Flap Periodontal Surgery: Advancing Personalized Periodontal Care through Minimally Invasive Technologies. J Contemp Dent Pract 2025;26(11):1025-1034.

13 June 2024
Verified
Book Chapter
Open access
PDF file
CNChariklia Neophytou
Chariklia Neophytou
KSKolovou Stolina
Kolovou Stolina
Konstantinos PapadimitriouKonstantinos Papadimitriou
Konstantinos Papadimitriou
ADAikaterini-Elisavet Doufexi
Aikaterini-Elisavet Doufexi
Dentistry is under continuous progress. Especially periodontal research and new therapeutic approaches have been developed in the last decades. The mechanism of periodontal disease development, diagnosis, classification system, and treatment protocol are disputed. At the same time, genetics with single-nucleotide polymorphisms (SNPs) signify the role of predisposition in periodontal disease. The relationship between periodontitis and systemic health is considered as an uncontested reality, and comorbidities with other diseases have been proved. Some recent advances and future perspectives in treatment field are immunomodulation, prebiotics, and vaccines, while biomaterials, like emdogain, and minimal invasive surgery are evolved frequently in periodontal treatment. This chapter presents and analyzes the total progress and changes in every aspect of periodontology from the past to now and the future.

9 May 2026 in Photobiomodulation, Photomedicine, and Laser Surgery
Verified
Journal Article
Closed access
CNChariklia Neophytou
Chariklia Neophytou
DSDimitra Sakellari
Dimitra Sakellari
IVIoannis Vouros
Ioannis Vouros
TSTheodora Slini
Theodora Slini
Serafeim C. ChaintoutisSerafeim C. Chaintoutis
Serafeim C. Chaintoutis
Konstantinos PapadimitriouKonstantinos Papadimitriou
Konstantinos Papadimitriou
Objective: To evaluate the clinical, microbiological, and patient-reported outcome measures (PROMs) of Er:YAG laser and photobiomodulation (PBM) therapy compared with conventional mechanical debridement (MD) in the nonsurgical treatment of peri-implantitis. Materials and Methods: Forty-five patients with peri-implantitis were randomly assigned to MD (control, n = 24) or Er:YAG laser followed by PBM (test, n = 21). Clinical parameters [probing depth (PD), bleeding on probing (BoP), clinical attachment level (CAL), plaque index, recession, suppuration] and levels of Porphyromonas gingivalis and Filifactor alocis were assessed at baseline and 3 months. Treatment success, defined as PD ≤ 5 mm, BoP at ≤ 1 site, and absence of suppuration, was assessed at 3 months. PROMs, including postoperative pain, analgesic use, anesthesia requirement, and satisfaction, were recorded during the first postoperative week. Results: Both groups showed significant clinical improvement ( p < 0.001). The laser group demonstrated greater reductions in PD (−2.30 vs. −1.45 mm, p < 0.001), BoP (−73.0% vs. −42.4%, p = 0.004), and CAL (−2.56 vs. −1.47 mm, p = 0.001), with higher treatment success (81% vs. 42%, p = 0.007). P. gingivalis decreased significantly only in the laser group ( p = 0.001), while F. alocis changes were not significant in both groups. PROMs favored the laser group, with lower postoperative pain, reduced analgesic use, and higher satisfaction ( p < 0.05). Conclusions: Adjunctive Er:YAG and PBM therapy improved clinical outcomes, reduced P. gingivalis , and enhanced patient experience compared with MD. Clinical Relevance: Er:YAG and PBM therapy may improve treatment success, enhance patient comfort, and support more predictable nonsurgical management of peri-implantitis.

9 December 2025
Verified
Preprint
Open access
CNChariklia Neophytou
Chariklia Neophytou
ANAvra Maria Neofytou
Avra Maria Neofytou
MPManousos Pissadakis
Manousos Pissadakis
ESEirini Salvanou
Eirini Salvanou
LPLouiza Papantonatou
Louiza Papantonatou
LBLeonidas Batas
Leonidas Batas